NCT06760442

Brief Summary

Statement of problem: The stability of peri-implant bone is a crucial factor for the long-term success of dental implants, where crestal bone plays a significant role in both the primary as well as the long- term implant stability. A bone loss of 1.5 mm during the first year of loading has been acceptable according to the early standards. However, more bone stability can be expected with the development in implant designs and surfaces over the past decades. Aim of the study: the aim of this study is to radiographically assess the crestal bone changes following delayed implant placement in mandibular previously augmented posterior sites, comparing cases with equicrestal implant placement with subcrestal implant placement

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Jan 2025Dec 2026

Study Start

First participant enrolled

January 1, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 6, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 27, 2026

Status Verified

January 1, 2025

Enrollment Period

1.5 years

First QC Date

January 3, 2025

Last Update Submit

January 26, 2026

Conditions

Keywords

crestal bone level changessubcrestal implant positioncrestal implant positionaugmented ridgedental implants

Outcome Measures

Primary Outcomes (1)

  • Crestal bone changes

    Periapical digital radiographs to determine the amount of crestal bone lose in mm

    at baseline,3, 6 ,12 and 18 months

Secondary Outcomes (2)

  • Keratinized tissue width

    at baseline, 3,6,12 and 18 months

  • Patient satisfaction

    at baseline, 6 ,12 and 18 months

Study Arms (2)

Subcrestal implant placement

ACTIVE COMPARATOR

Delayed implant placement 2 mm subcrestally in missing mandibular posterior site.

Procedure: Subcrestal implant placement

Crestal implant placement

ACTIVE COMPARATOR

Delayed implant placement equicrestally in missing mandibular posterior site.

Procedure: Crestal implant placement

Interventions

Delayed implant placement equicrestally in missing mandibular posterior site.

Crestal implant placement

Delayed implant placement 2 mm subcrestally in missing mandibular posterior site.

Subcrestal implant placement

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients older than 21 years.
  • Patients having augmented (by 50/50 particulate xenograft and autogenous bone) edentulous posterior site with vertical bone height of \> 10 mm in the mandible with a width of ridge ≥ 7 mm
  • Adequate Inter-arch space for implant placement
  • Favorable occlusion (no traumatic occlusion).
  • Good oral hygiene.•Accepts 18 months follow-up period (cooperative patient)
  • The patient provides informed consent.

You may not qualify if:

  • Patients with inadequate bone volume and/ or quality
  • Patients with remaining roots or with signs of acute infection related to the area of interest.
  • Patients having systemic conditions that interfere with normal wound healing
  • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits .
  • Smoker patients.
  • Pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Misr International University

Cairo, Egypt

RECRUITING

Study Officials

  • hani el nahas professor, Professor

    Misr International University

    STUDY CHAIR

Central Study Contacts

Hani El Nahas Professor, Professor

CONTACT

Zainab Hafez Abdel Rahman, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will not know whether the implant is placed crestal or subcrestal Outcome assessor (primary and secondary outcomes) \& biostatistician will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2025

First Posted

January 6, 2025

Study Start

January 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 27, 2026

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations